BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16119636)

  • 1. Neuroprotection possibilities in epileptic children.
    Artemowicz B; Sobaniec W
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():91-5. PubMed ID: 16119636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drugs and neuroprotection: current status and future roles.
    Willmore LJ
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
    Bootsma HP; Aldenkamp AP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsia; 2006; 47 Suppl 2():24-7. PubMed ID: 17105455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.
    Shi JQ; Wang BR; Tian YY; Xu J; Gao L; Zhao SL; Jiang T; Xie HG; Zhang YD
    CNS Neurosci Ther; 2013 Nov; 19(11):871-81. PubMed ID: 23889921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
    Huang CW; Pai MC; Tsai JJ
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anticonvulsant drugs.
    Stefan H; Feuerstein TJ
    Pharmacol Ther; 2007 Jan; 113(1):165-83. PubMed ID: 17030393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly emerging therapies for neonatal seizures.
    Pressler RM; Mangum B
    Semin Fetal Neonatal Med; 2013 Aug; 18(4):216-23. PubMed ID: 23688938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam.
    Klitgaard H; Pitkänen A
    Epileptic Disord; 2003 May; 5 Suppl 1():S9-16. PubMed ID: 12915336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting the challenge of treating epilepsy.
    Chadwick D; Wolf P
    Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroprotective activity of antiepileptic drugs].
    Czuczwar K; Czuczwar M; Cieszczyk J; Gawlik P; Luszczki JJ; Borowicz KK; Czuczwar SJ
    Przegl Lek; 2004; 61(11):1268-71. PubMed ID: 15727029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug.
    Cortes-Altamirano JL; Olmos-Hernández A; Bonilla-Jaime H; Bandala C; González-Maciel A; Alfaro-Rodríguez A
    Neurol India; 2016; 64(6):1266-1275. PubMed ID: 27841198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.
    Cavitt J; Privitera M
    Arch Neurol; 2004 Oct; 61(10):1604-7. PubMed ID: 15477517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on treatment of epilepsy in people with intellectual disabilities.
    Huber B; Seidel M
    Curr Opin Psychiatry; 2006 Sep; 19(5):492-6. PubMed ID: 16874122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
    Roberts GM; Majoie HJ; Leenen LA; Bootsma HP; Kessels AG; Aldenkamp AP; Leonard BE
    Epilepsy Behav; 2005 May; 6(3):366-72. PubMed ID: 15820345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
    Gibbs JE; Walker MC; Cock HR
    Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.